Literature DB >> 10373551

Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.

C D Novina1, S Kumar, U Bajpai, V Cheriyath, K Zhang, S Pillai, H H Wortis, A L Roy.   

Abstract

Bruton's tyrosine kinase (Btk) is required for normal B-cell development, as defects in Btk lead to X-linked immunodeficiency (xid) in mice and X-linked agammaglobulinemia (XLA) in humans. Here we demonstrate a functional interaction between the multifunctional transcription factor TFII-I and Btk. Ectopic expression of wild-type Btk enhances TFII-I-mediated transcriptional activation and its tyrosine phosphorylation in transient-transfection assays. Mutation of Btk in either the PH domain (R28C, as in the murine xid mutation) or the kinase domain (K430E) compromises its ability to enhance both the tyrosine phosphorylation and the transcriptional activity of TFII-I. TFII-I associates constitutively in vivo with wild-type Btk and kinase-inactive Btk but not xid Btk. However, membrane immunoglobulin M cross-linking in B cells leads to dissociation of TFII-I from Btk. We further show that while TFII-I is found in both the nucleus and cytoplasm of wild-type and xid primary resting B cells, nuclear TFII-I is greater in xid B cells. Most strikingly, receptor cross-linking of wild-type (but not xid) B cells results in increased nuclear import of TFII-I. Taken together, these data suggest that although the PH domain of Btk is primarily responsible for its physical interaction with TFII-I, an intact kinase domain of Btk is required to enhance transcriptional activity of TFII-I in the nucleus. Thus, mutations impairing the physical and/or functional association between TFII-I and Btk may result in diminished TFII-I-dependent transcription and contribute to defective B-cell development and/or function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373551      PMCID: PMC84330          DOI: 10.1128/MCB.19.7.5014

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.

Authors:  M Fukuda; T Kojima; H Kabayama; K Mikoshiba
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

2.  BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.

Authors:  W Yang; S Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

Authors:  M Vihinen; B H Belohradsky; R N Haire; E Holinski-Feder; S P Kwan; I Lappalainen; H Lehväslaiho; T Lester; A Meindl; H D Ochs; J Ollila; I Vorechovsky; M Weiss; C I Smith
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

4.  PH domains--a universal membrane adapter.

Authors:  B A Hemmings
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

5.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.

Authors:  M Hyvönen; M Saraste
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Regulatory intramolecular association in a tyrosine kinase of the Tec family.

Authors:  A H Andreotti; S C Bunnell; S Feng; L J Berg; S L Schreiber
Journal:  Nature       Date:  1997-01-02       Impact factor: 49.962

Review 7.  Role of Btk in B cell development and signaling.

Authors:  S Desiderio
Journal:  Curr Opin Immunol       Date:  1997-08       Impact factor: 7.486

8.  Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40.

Authors:  W N Khan; A Nilsson; E Mizoguchi; E Castigli; J Forsell; A K Bhan; R Geha; P Sideras; F W Alt
Journal:  Int Immunol       Date:  1997-03       Impact factor: 4.823

9.  Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase.

Authors:  K Salim; M J Bottomley; E Querfurth; M J Zvelebil; I Gout; R Scaife; R L Margolis; R Gigg; C I Smith; P C Driscoll; M D Waterfield; G Panayotou
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

10.  Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes.

Authors:  Y Oka; A G Rolink; J Andersson; M Kamanaka; J Uchida; T Yasui; T Kishimoto; H Kikutani; F Melchers
Journal:  Int Immunol       Date:  1996-11       Impact factor: 4.823

View more
  33 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Inhibition of TFII-I-dependent cell cycle regulation by p53.

Authors:  Zana P Desgranges; Jinwoo Ahn; Maria B Lazebnik; Todd Ashworth; Caleb Lee; Richard C Pestell; Naomi Rosenberg; Carol Prives; Ananda L Roy
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  Repression of TFII-I-dependent transcription by nuclear exclusion.

Authors:  M I Tussié-Luna; D Bayarsaihan; F H Ruddle; A L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Signal-induced functions of the transcription factor TFII-I.

Authors:  Ananda L Roy
Journal:  Biochim Biophys Acta       Date:  2007-10-11

5.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

6.  Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.

Authors:  Jaya Rajaiya; Jamee C Nixon; Neil Ayers; Zana P Desgranges; Ananda L Roy; Carol F Webb
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

7.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.

Authors:  María Isabel Tussié-Luna; Dashzeveg Bayarsaihan; Edward Seto; Frank H Ruddle; Ananda L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

8.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.

Authors:  Timothy A Hinsley; Pamela Cunliffe; Hannah J Tipney; Andrew Brass; May Tassabehji
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

10.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.